The University of Southampton
University of Southampton Institutional Repository

Evidence-based guidelines for anxiety disorders: can they improve clinical outcomes?

Evidence-based guidelines for anxiety disorders: can they improve clinical outcomes?
Evidence-based guidelines for anxiety disorders: can they improve clinical outcomes?
Evidence-based medicine (EBM) enables clinicians to justify decision making, enhances the quality of medical practice, identifies unanswered research questions, and ensures the efficient practice of medicine. Implementation of evidence-based mental health programs requires education, time, and improved effort by administration, regulatory, and clinical professionals. Essential to these efforts are consistent incentives for change, effective training materials, and clear clinical guidelines. Guidelines exist within the framework of EBM. Good guidelines are simple, specific, and user friendly, focus on key clinical decisions, are based on research evidence, and present evidence and recommendations in a concise and accessible format. Potential limitations of guidelines to improve clinical outcomes in anxiety disorders are the widespread distribution of anxiety symptoms in primary care, health inequalities across patient groups, persistent misconceptions regarding psychotropic drugs, and low confidence in using simple psychological treatments. Clinical guidelines generally specify therapeutic areas covered and not covered, but often there is no mention of cost or cost effectiveness of treatment. Guidelines can inform clinical decision making, but administrators of drug formularies may regard themselves as being primarily responsible for limiting costs and access to certain medications, even if these decisions are at odds with guideline recommendations.
impact, mental-health, randomized controlled-trial, management, primary-care patients, primary-care, depression, health, evidence-based guidelines, mental-disorders, disorders, antidepressants, project
1092-8529
34-39
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e

Baldwin, David S. (2006) Evidence-based guidelines for anxiety disorders: can they improve clinical outcomes? CNS Spectrums, 11 (10), supplement 12, 34-39.

Record type: Article

Abstract

Evidence-based medicine (EBM) enables clinicians to justify decision making, enhances the quality of medical practice, identifies unanswered research questions, and ensures the efficient practice of medicine. Implementation of evidence-based mental health programs requires education, time, and improved effort by administration, regulatory, and clinical professionals. Essential to these efforts are consistent incentives for change, effective training materials, and clear clinical guidelines. Guidelines exist within the framework of EBM. Good guidelines are simple, specific, and user friendly, focus on key clinical decisions, are based on research evidence, and present evidence and recommendations in a concise and accessible format. Potential limitations of guidelines to improve clinical outcomes in anxiety disorders are the widespread distribution of anxiety symptoms in primary care, health inequalities across patient groups, persistent misconceptions regarding psychotropic drugs, and low confidence in using simple psychological treatments. Clinical guidelines generally specify therapeutic areas covered and not covered, but often there is no mention of cost or cost effectiveness of treatment. Guidelines can inform clinical decision making, but administrators of drug formularies may regard themselves as being primarily responsible for limiting costs and access to certain medications, even if these decisions are at odds with guideline recommendations.

This record has no associated files available for download.

More information

Published date: October 2006
Keywords: impact, mental-health, randomized controlled-trial, management, primary-care patients, primary-care, depression, health, evidence-based guidelines, mental-disorders, disorders, antidepressants, project

Identifiers

Local EPrints ID: 62262
URI: http://eprints.soton.ac.uk/id/eprint/62262
ISSN: 1092-8529
PURE UUID: 77ef6158-b52c-4ae8-9bef-f106bacbec4a
ORCID for David S. Baldwin: ORCID iD orcid.org/0000-0003-3343-0907

Catalogue record

Date deposited: 06 Apr 2009
Last modified: 23 Jul 2022 01:39

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×